metformin has been researched along with chronic COVID syndrome in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin has clinical benefits when used as outpatient treatment for COVID-19 and is globally available, low-cost, and safe." | 3.30 | Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. ( Anderson, BJ; Beckman, KB; Belani, HK; Bhat, NS; Boulware, DR; Bramante, CT; Buse, JB; Cohen, K; Erickson, SM; Fenno, SL; Griffiths, G; Hartman, KM; Huling, JD; Karger, AB; Klatt, NR; Liebovitz, DM; Lindberg, SM; Mehta, T; Murray, TA; Nicklas, JM; Odde, DJ; Patel, B; Proper, JL; Pullen, M; Puskarich, MA; Rose, MR; Sherwood, NE; Siegel, LK; Thompson, JL; Tignanelli, CJ; Wirtz, EL, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bramante, CT | 1 |
| Buse, JB | 1 |
| Liebovitz, DM | 1 |
| Nicklas, JM | 1 |
| Puskarich, MA | 1 |
| Cohen, K | 1 |
| Belani, HK | 1 |
| Anderson, BJ | 1 |
| Huling, JD | 1 |
| Tignanelli, CJ | 1 |
| Thompson, JL | 1 |
| Pullen, M | 1 |
| Wirtz, EL | 1 |
| Siegel, LK | 1 |
| Proper, JL | 1 |
| Odde, DJ | 1 |
| Klatt, NR | 1 |
| Sherwood, NE | 1 |
| Lindberg, SM | 1 |
| Karger, AB | 1 |
| Beckman, KB | 1 |
| Erickson, SM | 1 |
| Fenno, SL | 1 |
| Hartman, KM | 1 |
| Rose, MR | 1 |
| Mehta, T | 1 |
| Patel, B | 1 |
| Griffiths, G | 1 |
| Bhat, NS | 1 |
| Murray, TA | 1 |
| Boulware, DR | 1 |
1 trial available for metformin and chronic COVID syndrome
| Article | Year |
|---|---|
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.
Topics: Adult; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Female; Fluvoxamine; Humans; Incidenc | 2023 |
1 other study available for metformin and chronic COVID syndrome
| Article | Year |
|---|---|
COVID-19 update: Metformin to prevent long COVID?
Topics: COVID-19; Humans; Hypoglycemic Agents; Ivermectin; Metformin; Post-Acute COVID-19 Syndrome; SARS-CoV | 2023 |